ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 60 filers reported holding ACCELERON PHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $86,548,000 | +36.8% | 502,898 | -0.3% | 0.02% | +41.7% |
Q2 2021 | $63,288,000 | -14.2% | 504,333 | -7.2% | 0.01% | -20.0% |
Q1 2021 | $73,723,000 | +19.3% | 543,646 | +12.6% | 0.02% | +15.4% |
Q4 2020 | $61,778,000 | +20.2% | 482,864 | +5.7% | 0.01% | 0.0% |
Q3 2020 | $51,401,000 | +64.3% | 456,782 | +39.1% | 0.01% | +62.5% |
Q2 2020 | $31,286,000 | -3.0% | 328,389 | -8.5% | 0.01% | -27.3% |
Q1 2020 | $32,256,000 | -17.5% | 358,905 | -51.3% | 0.01% | +10.0% |
Q4 2019 | $39,112,000 | +34.4% | 737,693 | +0.2% | 0.01% | +25.0% |
Q3 2019 | $29,096,000 | +48.5% | 736,462 | +54.4% | 0.01% | +60.0% |
Q2 2019 | $19,595,000 | -13.0% | 477,016 | -1.4% | 0.01% | -16.7% |
Q1 2019 | $22,531,000 | +17.7% | 483,811 | +10.0% | 0.01% | 0.0% |
Q4 2018 | $19,147,000 | +76.6% | 439,644 | +132.1% | 0.01% | +100.0% |
Q3 2018 | $10,839,000 | +30.6% | 189,390 | +10.7% | 0.00% | +50.0% |
Q2 2018 | $8,302,000 | +27.8% | 171,104 | +3.0% | 0.00% | 0.0% |
Q1 2018 | $6,494,000 | -7.3% | 166,076 | +0.7% | 0.00% | 0.0% |
Q4 2017 | $7,002,000 | +13.2% | 164,959 | -0.4% | 0.00% | 0.0% |
Q3 2017 | $6,183,000 | +46.8% | 165,645 | +19.5% | 0.00% | +100.0% |
Q2 2017 | $4,211,000 | +32.2% | 138,561 | +15.2% | 0.00% | 0.0% |
Q1 2017 | $3,185,000 | -8.0% | 120,292 | -11.3% | 0.00% | 0.0% |
Q4 2016 | $3,462,000 | -27.5% | 135,621 | +2.9% | 0.00% | 0.0% |
Q3 2016 | $4,772,000 | +2.0% | 131,861 | -4.2% | 0.00% | 0.0% |
Q2 2016 | $4,679,000 | +34.5% | 137,689 | +4.5% | 0.00% | 0.0% |
Q1 2016 | $3,478,000 | -33.4% | 131,723 | +22.9% | 0.00% | -50.0% |
Q4 2015 | $5,225,000 | +117.3% | 107,145 | +11.0% | 0.00% | +100.0% |
Q3 2015 | $2,404,000 | -18.6% | 96,530 | +3.4% | 0.00% | 0.0% |
Q2 2015 | $2,954,000 | +7.8% | 93,359 | +29.6% | 0.00% | 0.0% |
Q1 2015 | $2,741,000 | +0.4% | 72,032 | +2.9% | 0.00% | 0.0% |
Q4 2014 | $2,729,000 | +33.4% | 70,021 | +3.5% | 0.00% | 0.0% |
Q3 2014 | $2,046,000 | -50.4% | 67,660 | -44.2% | 0.00% | 0.0% |
Q2 2014 | $4,122,000 | +264.1% | 121,304 | +269.9% | 0.00% | – |
Q1 2014 | $1,132,000 | +27.8% | 32,795 | +46.6% | 0.00% | – |
Q4 2013 | $886,000 | – | 22,367 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |